Publication | Closed Access

Daunorubicin, a topoisomerase II poison, suppresses viral production of hepatitis B virus by inducing cGAS-dependent innate immune response

Viral ProductionViral HepatitisMedicinePathogenesisImmunologyAntiviral TherapyHepatitisAntiviral ResponseTopoisomerase Ii PoisonInnate ImmunityAntiviral DrugHepatitis B VirusPharmacologyDrug Resistance